TauRX Pharmaceuticals Company
Leader in Alzheimer's disease research, TauRx's mission is to discover, develop and commercialize innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2002
Employees Number:
501-1000
Funding Status:
Private Equity
Investors Number:
2
Total Funding:
257500000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2016
Last Funding Type:
Private Equity
Register and Claim Ownership